PUBLICATIONS
Manufacturing CD20/CD19-targeted iCasp9 regulatable CAR-TSCM cells using a Quantum pBac-based CAR-T engineering system
DOI: 10.1371/journal.pone.0309245
Journal: PLoS One (2024)
Quantum pBac: An effective, high-capacity piggyBac-based gene integration vector system for unlocking gene therapy potential
DOI: 10.1096/fj.202201654R
Journal: FASEB Journal (2023)
Manufacturing CD20/CD19-Targeted iCasp9 Regulatable CAR-TSCM Cells Using qCART, the Quantum pBac-based CAR-T System
DOI: 10.1101/2022.05.03.490475
Journal: Under review, preprint in bioRxiv (2022)
Quantum CART (qCART), A piggyBac-Based System for Development and Production of Virus-Free Multiplex CAR-T Cell Therapy
DOI: 10.1101/2022.05.03.490469
Journal: Under review, preprint in bioRxiv (2022)
Quantum CART (qCART), A piggyBac-based System for Development and Production of Nonviral Multiplex CAR-T Cell Therapy
Poster presentation at 7th CAR-TCR summit (2022)
Comparison of Chimeric Antigen Receptor-T Cell-Mediated Cytotoxicity Assays with Suspension Tumor Cells Using Plate-Based Image Cytometry Method
DOI: 10.1002/cyto.a.24673
Journal: Cytometry Part A (2022)
EpEX/EpCAM and Oct4 or Klf4 Alone Are Sufficient to Generate Induced Pluripotent Stem Cells Through STAT3 and HIF2α
DOI: 10.1038/srep41852
Journal: Scientific Reports (2017)
A Versatile, Highly Efficient, and Potentially Safer piggyBac Transposon System for Mammalian Genome Manipulations
DOI: 10.1096/fj.12-223586
Journal: The FASEB Journal (2013)
Genome-Wide Target Profiling of piggyBac and Tol2 in HEK 293: Pros and Cons for Gene Discovery and Gene Therapy
DOI: 10.1186/1472-6750-11-28
Journal: BMC Biotechnology (2011)
Transposon-Based Vector Systems for Gene Therapy Clinical Trials: Challenges and Considerations